Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma

Jean C. Tien(University of Michigan), Arul M. Chinnaiyan(University of Michigan), Yuanyuan Qiao(University of Michigan), Jianzhang Yang(Jinan University), Jonathan Chou(University of California, San Francisco), Fengyun Su(University of Michigan), Somnath Mahapatra(University of Michigan), Yu‐Sun Chang(Chang Gung University of Science and Technology), Kathleen R. Cho(University of Michigan), Xuhong Cao(Howard Hughes Medical Institute), Rong Wu(Nanjing Forestry University), Marcin Cieślik(University of Michigan), Carmine Stolfi(University of Rome Tor Vergata), Brian Magnuson, Rahul Mannan(University of Michigan), Yuping Zhang(University of Michigan), Christina Wheeler(University of Michigan), Eric R. Fearon(Cancer Genetics (United States)), Zhen Wang(Shanghai Institute of Organic Chemistry), Rui Wang(University of Michigan), Shuqin Li(Xuzhou Medical College), Xiaoju Wang(Zhejiang Academy of Medical Sciences), Yunhui Cheng(University of Michigan), Caleb Cheng(University of Michigan), Yizhi Cao(Nanjing Medical University), Lanbo Xiao(University of Michigan), Yali Zhai(University of Michigan), Abigail J. Todd(University of Michigan), Ke Ding(Chinese Academy of Sciences), Gabriel Cruz(University of Michigan), Licheng Zhou(Jinan University)

Proceedings of the National Academy of Sciences

June 12, 2025

Cited by 6

|Cell|2015|3.6k

|Nature|2002|2.7k

|New England Journal of Medicine|2015|2.2k

|Science|1989|2.1k

|Science|1989|1.3k

Related Papers